Complementary and alternative medicine (CAM) is the term used to describe many kinds of products, practices, and systems that are not part of conventional medicine. Cancer patients usually do everything they can to combat the disease, manage its symptoms, and cope with the side effects of treatment. Unfortunately, patients who use CAM underestimate the risk of interaction with cancer therapy or worse they omit conventional therapy thus reducing the possibility of cancer remission. Herein we analyzed the effects of Vidatox 30 CH (venom extracted from the Junceus Rhopalurus scorpion) on hepatocellular carcinoma (HCC), the second leading cause of cancer-related deaths. We found out that Vidatox increases HCC proliferation and invasion whereas it does not seem to interact with sorafenib, the orally active multikinase inhibitor approved for the treatment of advanced hepatocellular carcinoma. Our results suggest that the concentration of Vidatox used in the present study has not anti-neoplastic effects and care must be taken in hiring Vidatox in patients with HCC.

Giovannini, C., Baglioni, M., Baron Toaldo, M., Cescon, M., Bolondi, L., Gramantieri, L. (2017). Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma. SCIENTIFIC REPORTS, 7, 1-11 [10.1038/srep44685].

Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma

GIOVANNINI, CATIA;BAGLIONI, MICHELE;BARON TOALDO, MARCO;CESCON, MATTEO;BOLONDI, LUIGI;GRAMANTIERI, LAURA
2017

Abstract

Complementary and alternative medicine (CAM) is the term used to describe many kinds of products, practices, and systems that are not part of conventional medicine. Cancer patients usually do everything they can to combat the disease, manage its symptoms, and cope with the side effects of treatment. Unfortunately, patients who use CAM underestimate the risk of interaction with cancer therapy or worse they omit conventional therapy thus reducing the possibility of cancer remission. Herein we analyzed the effects of Vidatox 30 CH (venom extracted from the Junceus Rhopalurus scorpion) on hepatocellular carcinoma (HCC), the second leading cause of cancer-related deaths. We found out that Vidatox increases HCC proliferation and invasion whereas it does not seem to interact with sorafenib, the orally active multikinase inhibitor approved for the treatment of advanced hepatocellular carcinoma. Our results suggest that the concentration of Vidatox used in the present study has not anti-neoplastic effects and care must be taken in hiring Vidatox in patients with HCC.
2017
Giovannini, C., Baglioni, M., Baron Toaldo, M., Cescon, M., Bolondi, L., Gramantieri, L. (2017). Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma. SCIENTIFIC REPORTS, 7, 1-11 [10.1038/srep44685].
Giovannini, Catia; Baglioni, Michele; Baron Toaldo, Marco; Cescon, Matteo; Bolondi, Luigi; Gramantieri, Laura
File in questo prodotto:
File Dimensione Formato  
srep44685.pdf

accesso aperto

Descrizione: Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma.
Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 2.56 MB
Formato Adobe PDF
2.56 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/594000
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 14
  • ???jsp.display-item.citation.isi??? 11
social impact